Latest Breaking News On - Hospital affiliated - Page 4 : comparemela.com

Junshi Biosciences Announces Lancet Infectious Diseases

SHANGHAI, China, Nov. 22, 2023 (GLOBE NEWSWIRE) Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading.

United statesYun lingZhi liJunshi biosciencesXinjiang technical institute of physicsWuhan institute of virologyCentral asian centerShanghai junshi biosciences co ltdShanghai public health clinical centerGlobal researchShanghai institute of materia medicaDevelopment chinese academy of sciences chinaIr teamVigonvita life sciences co ltdPr teamLingang laboratory

Junshi Biosciences Announces Lancet Infectious Diseases Publication of Results from the 2nd Phase 3 Study of VV116 for Treating COVID-19

Junshi Biosciences Announces Lancet Infectious Diseases Publication of Results from the 2nd Phase 3 Study of VV116 for Treating COVID-19
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesYun lingStefan klotterZhi liJunshi biosciencesVigonvita life sciences co ltdLingang laboratoryIr teamChinese academy of sciencesShanghai institute of materia medicaGlobal researchCentral asian centerXinjiang technical institute of physicsPr teamDevelopment chinese academy of sciences chinaWuhan institute of virology

New approach in the treatment of non-alcoholic fatty liver disease (NAFLD)

New approach in the treatment of non-alcoholic fatty liver disease (NAFLD)
idw-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from idw-online.de Daily Mail and Mail on Sunday newspapers.

Baden wübergUnited statesWeiping jiaGianni panagiotouWissenschaftliche ansprechpartnerHuating liWissenschaftliche publikationenWeitere informationenGerman research foundationLeibniz associationWorld health organisationUniversity of jenaLeibniz institute for natural product researchNieber abteilungBereich presseShanghai sixth people

Research shows how resistant starch could slow down progression of non-alcoholic fatty liver disease

The prebiotic resistant starch could play an important role in the treatment of non-alcoholic fatty liver disease (NAFLD) in the future.

United statesHuating liGianni panagiotouDanielle ellisWeiping jiaGerman research foundationWorld health organisationLeibniz associationLeibniz institute for natural product researchUniversity of jenaShanghai sixth peopleHospital affiliatedShanghai jiao tong university schoolLeibniz instituteNatural product researchInfection biology

Tranexamic acid use linked to decreased incidence of heterotopic ossification after elbow trauma surgery

For patients undergoing surgery for elbow trauma, treatment with the hemostatic drug tranexamic acid (TXA) is associated with a decreased incidence of heterotopic ossification (HO) – a common complication of abnormal bone formation, reports a study in The Journal of Bone & Joint Surgery.

Danielle ellisWolters kluwerCunyi fanShanghai sixth peopleHospital affiliatedShanghai jiao tong university schoolTranexamic acidAnti inflammatory